Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Pharmaceutical Stocks Worth Watching - July 18th - Stock Observer
Heartland Bank & Trust Co Purchases 5,308 Shares of AbbVie Inc. $ABBV - Markets Daily
Ranch Capital Advisors Inc. Raises Stake in AbbVie Inc. $ABBV
26,081 Shares in AbbVie Inc. $ABBV Acquired by Independent Financial Group LLC - Markets Daily
Ranch Capital Advisors Inc. Purchases 4,017 Shares of AbbVie Inc. $ABBV - Stock Observer
FSA Advisors Inc. Has $559,000 Stock Holdings in AbbVie Inc. $ABBV - Daily Political
VYM's $94.6 Billion Portfolio Beats Treasury Yields with Dividend Kings Leading the Way
AbbVie (ABBV) Boey Approval Puts Its Growth Story And Valuation Back In Focus
EU Approves Allergan Aesthetics' Boey For Treatment Of Frown Lines
Erste Group Bank Has Negative View of AbbVie FY2026 Earnings
Medical Stocks To Add to Your Watchlist - July 17th - Daily Political
AbbVie Inc. $ABBV Shares Bought by Financiere des Professionnels Fonds d investissement inc.
Bessemer Group Inc. Buys 42,695 Shares of AbbVie Inc. $ABBV - Stock Observer
SteelPeak Wealth LLC Reduces Holdings in AbbVie Inc. $ABBV - Daily Political
Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia
AbbVie (NYSE:ABBV) Shares Up 4.2% - Time to Buy?
4,410 Shares in AbbVie Inc. $ABBV Purchased by Navigation Group LLC - Zolmax
Navigation Group LLC Takes Position in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Sold by Midwest Professional Planners LTD.
Is AbbVie (ABBV) Fully Priced Despite Tepkinly Approval And Cash Flow?
AbbVie Inc. (NYSE:ABBV) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial
Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results
Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage
J&J falls despite a beat-and-raise quarter. Why we're raising our price target anyways
AbbVie (ABBV) Gets $260 Price Target Upgrades Amid Growing Valuation Worries
AbbVie Strengthens Immunology Leadership with $10.9 Billion Apogee Therapeutics Acquisition
AbbVie vs Baxter: One Golden Cross Is Real, One Is a Trap
AbbVie (ABBV) Builds SkinMedica Regenerative Science Board As It Expands Aesthetics
AbbVie Inc. $ABBV Stock Position Cut by CFO Capital Management LLC
Traders Buy High Volume of Call Options on AbbVie (NYSE:ABBV) - Stock Observer
ABBVIE SP. Z O.O. secures contract for Pharmaceutical products, Antineoplastic and immunomodulating agents
AbbVie Target of Unusually High Options Trading (NYSE:ABBV)
AbbVie (NYSE:ABBV) Shares Down 1.3% - Here's Why
AbbVie Currently Down Seven Consecutive Days, On Pace for Longest Losing Streak Since March 2025 - Data Talk | Morningstar
Ironwood Appoints Dr. Jeffrey Silber Chief Medical Officer and Head of Research and Drug Development; STARS-2 Trial Initiated in June and Is Now Actively Recruiting Patients
Calamos Advisors LLC Acquires 17,380 Shares of AbbVie Inc. $ABBV - Zolmax
Calamos Advisors LLC Purchases 17,380 Shares of AbbVie Inc. $ABBV
Bleakley Financial Group LLC Sells 2,871 Shares of AbbVie Inc. $ABBV - Stock Observer
Equities Research Analysts' Price Target Changes for July 13th (ABBV, ABX, AEP, AFL, AGCO, AGEN, AJG, ALKS, ALNT, ALNY) - Markets Daily
BMO Capital Markets Issues Positive Forecast for AbbVie (NYSE:ABBV) Stock Price
Parr Mcknight Wealth Management Group LLC Sells 10,690 Shares of AbbVie Inc. $ABBV - Zolmax
AbbVie Inc. $ABBV Shares Acquired by Teachers Retirement System of The State of Kentucky - Markets Daily
Lifeworks Advisors LLC Increases Holdings in AbbVie Inc. $ABBV - Zolmax
AbbVie Inc. $ABBV Shares Sold by Triglav Investments D.O.O.
AbbVie Inc. $ABBV Shares Purchased by J. Safra Sarasin Holding AG
AbbVie Inc. $ABBV Shares Acquired by Teachers Retirement System of The State of Kentucky
Berenberg Bank Sticks to Its Buy Rating for AstraZeneca (AZN)
AbbVie Employees Across Asia Unite Through Week of Possibilities by Serving and Supporting Communities
AbbVie Inc. $ABBV Shares Bought by Midwest Trust Co - Markets Daily
AbbVie Inc. $ABBV Shares Sold by Cullinan Associates Inc.
AbbVie Inc. $ABBV Shares Acquired by Carnegie Investment Counsel
Cullinan Associates Inc. Reduces Position in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Sold by Citizens Financial Group Inc. RI
Fifth Third Bancorp Increases Stock Holdings in AbbVie Inc. $ABBV
Midwest Trust Co Increases Stake in AbbVie Inc. $ABBV - Stock Observer
AbbVie Inc. $ABBV Position Boosted by Fifth Third Bancorp - Daily Political
Candriam S.C.A. Has $248.95 Million Position in AbbVie Inc. $ABBV - Markets Daily
Simplicity Wealth LLC Raises Holdings in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV is Osprey Private Wealth LLC's 5th Largest Position - Stock Observer
Candriam S.C.A. Grows Position in AbbVie Inc. $ABBV
Conning Inc. Purchases 6,523 Shares of AbbVie Inc. $ABBV
AbbVie (NYSE:ABBV) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - Stock Observer
AbbVie (NYSE:ABBV) Given New $280.00 Price Target at Royal Bank Of Canada - Daily Political
West Pharmaceutical Services (WST) Sells SmartDose Rights, Is The Stock Fully Priced?
SPECTRUM: Early clinical experience from the first global real-world study of aflibercept 8 mg in patients with diabetic macular oedema
2 'Strong Buy' Dividend Aristocrat Stocks to Grab Right Now for August Payouts
West Pharmaceutical Services (WST) Sells SmartDose Rights To AbbVie To Refocus Its Business
Analysts' Price Target Changes for July 10th (ABBV, ACX, ATZ, BBAR, BCE, BKH, BMY, CCA, CNR, CP) - Markets Daily
Top Pharmaceutical Stocks To Follow Now - July 10th
Bank of America Issues Positive Forecast for AbbVie (NYSE:ABBV) Stock Price
Top Medical Stocks To Consider - July 10th - Zolmax
Johnson & Johnson vs AbbVie: Two Paths to Pharma Dominance, One Winner - AOL
Royal Bank Of Canada Issues Positive Forecast for AbbVie (NYSE:ABBV) Stock Price
Kestra Advisory Services LLC Raises Stock Position in AbbVie Inc. $ABBV - Zolmax
AbbVie Inc. $ABBV Shares Sold by Griffin Asset Management Inc. - Zolmax
Ibex Wealth Advisors Raises Position in AbbVie Inc. $ABBV
3 Psychedelic Stocks With Potential Clinical Trial Catalysts
U.S. House committee investigates pharmaceutical giants for clinical trials at Chinese military hospitals - NaturalNews.com
ABBV: Future Returns Will Depend On Apogee Deal And Broader Immunology Expansion
Systemic Lupus Erythematosus Market at a Turning Point as 6 Late-Stage Emerging Therapies Set to Redefine Treatment Landscape | DelveInsight
JPMorgan Chase & Co. Issues Positive Forecast for AbbVie (NYSE:ABBV) Stock Price
One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics
AbbVie Inc. $ABBV Stock Holdings Lifted by Stenger Family Office LLC - Stock Observer
AbbVie (NYSE:ABBV) Updates FY 2026 Earnings Guidance - Daily Political
Cellular therapy in mantle cell lymphoma: recommendations from the EBMT practice harmonisation and guidelines committee
Prediagnostic opioid use and survival in multiple myeloma: a nationwide register-based study
Attitudes of specialist memory-clinic patients with early symptomatic Alzheimer's disease towards lecanemab: results from a multicenter survey in Europe
AbbVie (ABBV) Wins EU Approval For Tepkinly, Is The Stock Fully Valued?
Pharmaceutical Stocks To Watch Now - July 8th - Markets Daily
Montag A & Associates Inc. Reduces Holdings in AbbVie Inc. $ABBV - Zolmax
AbbVie News
Nasdaq 100 Forecast: Index Tests Critical Resistance Amid Cooler Inflation and Resurgent Geopolitical Risks
8 Best Interactive Brokers Alternatives in 2026 (Ranked by Fees & Usability)
Latest news
Show more
EUR to USD Exchange Rate Today (July 17): Euro Slips Against the US Dollar as Traders Assess Fed Outlook
Nikkei 225 Slides Nearly 3% as Kioxia and SoftBank Lead Japan Tech Selloff
USD to JPY Exchange Rate Today (July 17): Dollar Holds Firm as Yen Stays Near Multi-Decade Lows
